Lumiracoxib Market In Global
Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exh ... Read More
Tolcapone is a reversible inhibitor of catechol-O-methyltransferase.
This report contains market size and forecasts of Tolcapone in global, including the following market information:
Global Tolcapone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tolcapone Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Tolcapone companies in 2021 (%)
The global Tolcapone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tolcapone include Bio-Techne, Santa Cruz Biotechnology, Merck, Cayman Chemical, Abcam, TCI, AbMole, BOC Sciences and Key Organics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tolcapone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tolcapone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tolcapone Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Tolcapone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tolcapone Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Tolcapone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tolcapone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tolcapone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tolcapone revenues share in global market, 2021 (%)
Key companies Tolcapone sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Tolcapone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
Santa Cruz Biotechnology
Merck
Cayman Chemical
Abcam
TCI
AbMole
BOC Sciences
Key Organics
Sinopaharrm Chemical Reagent
Clearsynth
Biosynth Carbosynth
Selleck Chemicals
StressMarq Biosciences
Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exh ... Read More
Cenicriviroc is an experimental drug candidate for the treatment of HIV infection.Cenicriviroc is ... Read More
Mizolastine is a second generation antihistamine agent with high affinity and specificity for his ... Read More
Bepotastine is a non-sedating, selective antagonist of histamine 1 (H1) receptor with pIC50 of 5. ... Read More